Physician profile
Nicholas Wilhelm
NPI 1578919775
$5,148.21
in general payments reported to CMS, 2019-2025
43 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $666 · 2021: $528 · 2022: $603 · 2023: $931 · 2024: $1,061 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,082.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $946.96 | 2020-2025 | Vraylar, Qulipta, Viberzi |
| Novo Nordisk INC | $443.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $365.74 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $329.57 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Pfizer INC. | $289.42 | 2023-2025 | |
| Astellas Pharma US INC | $218.74 | 2020-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.11 | 2019-2025 | Jardiance |
| Exact Sciences Corporation | $194.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $187.98 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $180.84 | 2019-2024 | Belsomra, Steglatro, Gardasil 9 |
| Amgen INC. | $176.85 | 2019-2024 | Repatha, Otezla |
| Dexcom, INC. | $172.97 | 2021-2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $155.43 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.79 | 2020-2024 | Xifaxan |
| Allergan, INC. | $137.90 | 2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Wilhelm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.